Structures and mechanism of action of Comp-NPs for the diagnosis by imaging and treatment of tumors by multimodal photodynamic therapy and immunotherapy. a) Chemical structures of a polymer incorporating a chromophore for imaging upon irradiation at 808?nm (P1) or a photosensitizer for PDT upon irradiation at 650?nm (P2). b) Self-assembly of the polymers into the nanoparticles NP1 and NP2. The theranostic nanoparticle formulation Comp-NPs is generated by mixing NP1 and NP2. c) Biological mechanism of action of Comp-NPs by combined photodynamic therapy and immunotherapy.
Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-40826-5
An international research team headed by Dr. Johannes Karges of the Faculty of Chemistry and Biochemistry at Ruhr University Bochum, Germany, has developed nanoparticles that accumulate in cancer cells and eliminate them after being photoactivated.
In addition, they label them in such a way that immune cells learn to eliminate similar cells throughout the body. This means that even undetected metastases can be treated. The researchers presented their findings in the journal Nature Communications of 2 September 2023.
The malicious nature of cancers means that they spread throughout the body: cells from the primary tumor grow into surrounding tissue and travel through the bloodstream and lymphatic system to distant organs, where they form secondary metastatic tumors. “While we now have effective methods to combat primary tumors, metastases are still very difficult to treat,” explains Johannes Karges. “Ninety percent of people who die from cancer die from metastases and tumor regression, not from the primary tumor.”
Together with an international team, he’s developed a drug packaged in nanoparticles that are administered into the bloodstream. “Tumors grow rapidly and uncontrollably, and their tissue is therefore leaky,” he describes. “Unlike in healthy tissues, the nanoparticles therefore accumulate in them easily.” This also means that the particles preferentially accumulate in tumor cells.
Step one: treating a known tumor
At the time of administration, the drug is still ineffective. It only takes effect when activated with light. If there are sufficient nanoparticles in a detected tumor, they can be activated by irradiation with light, for example during surgery. After this energy supply, the active species ensures that immunogenic cell death occurs: the tumor cells containing the photoactivated nanoparticles are eliminated, and the tumor treated by this method disappears.
Step two: sending immune cells on a search
But that’s not all: the nanoparticles and their light-induced effect cause massive oxidative stress in the endoplasmic reticulum of the cells of the treated tumor. “This alerts the body’s own immune system,” explains Johannes Karges. “The immune cells recognize that something is going completely wrong in cells of this type, and that such cells therefore need to be eliminated.” This applies not only to the cells of the photo-treated tumor itself, but to all cells of the same kind throughout the body. “Accordingly, the immune system starts looking for further metastases and renders them harmless,” says Johannes Karges.
The research team proved this active principle in experiments on cancer cells and in animal models. They applied it to effectively treat mice that had been implanted with cells from metastasized and incurable human tumors. “Now, we’re looking for industrial partners who will help us undertake more in-depth studies,” says Johannes Karges. He expects that several more years of development work will be needed before the technology can be widely used in clinical applications.
Original Article: New compound unleashes the immune system on metastases
More from: Ruhr University Bochum
The Latest Updates from Bing News
Go deeper with Bing News on:
- Medtronic secures 510(k) clearance for bone metastases ablation system
Medtronic has received 510(k) clearance from the US Food and Drug Administration (FDA) for the OsteoCool 2.0 ablation system to treat painful bone metastases. The system is also designed to treat ...
- Cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment
An important discovery from the NCI-MATCH precision medicine initiative is published in Clinical Cancer Research.
- An overview of adrenal metastasis
This article looks at the symptoms, causes, and diagnosis of adrenal metastasis. It also discusses the treatment options and outlook for the condition. Adrenal metastasis may be unilateral ...
- Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)
Phase 2 trial in patients with RAS-mutated mCRC will evaluate onvansertib plus SoC versus SoC alone in the first-line setting -- Pfizer Ignite ...
- The Future of Innovation Metastatic Breast Cancer: 2024 Outlook
While the past several decades have seen progress in early detection, recent innovations in metastatic breast cancer—or cancer that has spread to distant parts of the body, including the bone, brain, ...
Go deeper with Bing News on:
- Analysis of Orthopedic Surgery of Bone Metastases in Breast Cancer Patients
Because bone metastases are a common finding in patients with breast cancer, they are of major clinical concern. Methods In 115 consecutive patients with bone metastases secondary to breast cancer ...
- Brain Metastases From Prostate Cancer
Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.
- Understanding the Difference Between Invasive and Metastatic Breast Cancer
Metastatic breast cancer is a specific stage of cancer indicating the spread to distant parts of the body. Abnormal cells aren’t cancerous, but they may increase your risk of developing cancer.
- Eduard Batlle, molecular biologist: ‘Tumor cells are high-speed evolution machines’
A. Tumor cells act as high-speed evolution machines. Their adaptability makes them incredibly resilient. In the past, we believed that targeting a specific gene mutation or using a particular therapy ...
- Chronic Stress Increases Risk of Cancer Metastasis
Working with CSHL Professor Linda Van Aelst, they discovered that stress causes certain white blood cells called neutrophils to form sticky web-like structures that make body tissues more susceptible ...